Evaxion Biotech A/S (EVAX)
NASDAQ·Healthcare·Biotechnology
$3.18
+4.61%
Mkt Cap $19.45M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$11.67
Range $9.00 – $16.00
Implied Upside
+267.0%
Consensus $11.67 vs current $3.18
NASDAQ·Healthcare·Biotechnology
$3.18
+4.61%
Mkt Cap $19.45M
No recent rating data.
Price Target (4 analysts)
$11.67
Range $9.00 – $16.00
+267.0%
Consensus $11.67 vs current $3.18